echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Approval | NMPA 2020 transcript: 1,096 innovative drugs were approved for clinical use, and 20 were approved for production...

    Approval | NMPA 2020 transcript: 1,096 innovative drugs were approved for clinical use, and 20 were approved for production...

    • Last Update: 2021-05-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On April 20, the State Food and Drug Administration issued the "Annual Report on Drug Administration Statistics (2020)".
    The report shows that in 2020, the State Food and Drug Administration will accept 587 imported clinical trial applications and 3397 applications for supplementary approval in provinces and cities; 1,096 innovative drugs have been approved for clinical use, and 20 innovative drugs have been approved for production, of which only 2 are biological products; 879 new drugs have been clinically approved, including 9 Chinese natural medicines.
    .
    .

    On April 20, the State Food and Drug Administration issued the "Annual Report on Drug Administration Statistics (2020)".
    The report shows that in 2020, the State Food and Drug Administration will accept 587 imported clinical trial applications and 3397 applications for supplementary approval in provinces and cities; 1,096 innovative drugs have been approved for clinical use, and 20 innovative drugs have been approved for production, of which only 2 are biological products; 879 new drugs have been clinically approved, including 9 Chinese natural medicines.
    .
    .

    Drug Administration Acceptance Situation

    Drug Administration Acceptance Situation

    587 imported clinical trial applications accepted

    587 imported clinical trial applications accepted

    3397 provincial and municipal supplementary approval applications

    The report shows that in 2020, the National Bureau will accept 587 clinical trial applications for imported drugs (including Hong Kong, Macao and Taiwan), 300 marketing applications, 320 re-registration applications, and 3685 supplementary applications; 1099 clinical trial applications for domestic drugs and 1076 marketing applications will be accepted , 1520 supplementary applications; 881 applications for quality and efficacy consistency evaluation of generic drugs and 489 temporary import applications were accepted.





    In 2020, provincial (autonomous regions and municipalities) bureaus received 3397 applications for supplementary drug approval, 25,638 applications for supplementary drug filing, and 90094 applications for re-registration.
    108 first-time applications for imported medicinal materials, 337 non-first-time applications, and 6 supplementary applications were accepted.





    Drug registration approval status



    879 new drugs were clinically approved, and biopharmaceuticals accounted for 223

    According to the report, in 2020, the State Food and Drug Administration approved a total of 879 clinical applications for new drugs (excluding imported drugs), including 9 natural Chinese medicines, 647 chemical drugs, and 223 biological products; a total of 181 clinical applications were approved according to the new drug application procedures.
    Among them, 11 are traditional Chinese medicines and natural medicines, 97 are chemical medicines, and 73 are biological products.





    1,096 innovative drugs were approved for clinical use, and 20 were approved for production

    In 2020, a total of 1,096 clinical varieties of innovative drugs have been approved, and 20 production varieties of innovative drugs have been approved.







    604 imported clinical drugs were approved and 128 were on the market

    In 2020, a total of 604 clinical imported medicines were approved, including 223 biological products, 380 chemical medicines, and 1 Chinese medicine natural medicine; in addition, 128 will be approved for marketing, with 49 biological products and 79 chemical medicines.





    722 generic drugs approved clinically

    In 2020, a total of 41 generic drugs were approved for clinical trials, and 722 were produced.







    For more details, please check the original report:





    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.
    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.